Wave Life Sciences Ltd (WVE) ticks all the boxes for top investors with its surprise performance of 9.45% last month.

Wave Life Sciences Ltd (NASDAQ: WVE) kicked off on Friday, down -3.47% from the previous trading day, before settling in for the closing price of $7.20. Over the past 52 weeks, WVE has traded in a range of $4.25-$16.74.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 46.62% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -51.95%. With a float of $123.09 million, this company’s outstanding shares have now reached $154.09 million.

In an organization with 288 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -119.83%, and the pretax margin is -107.04%.

Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.14%, while institutional ownership is 81.46%. The most recent insider transaction that took place on Jun 13 ’25, was worth 208,500. In this transaction Director of this company sold 30,000 shares at a rate of $6.95, taking the stock ownership to the 282,517 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 30,000 for $7.20, making the entire transaction worth $216,000.

Wave Life Sciences Ltd (WVE) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -51.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.44% during the next five years compared to 34.27% growth over the previous five years of trading.

Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators

Take a look at Wave Life Sciences Ltd’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 2.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.21.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.11 in one year’s time.

Technical Analysis of Wave Life Sciences Ltd (WVE)

Let’s dig in a bit further. During the last 5-days, its volume was 0.92 million. That was inferior than the volume of 1.24 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 74.39%. Additionally, its Average True Range was 0.41.

During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 23.07%, which indicates a significant decrease from 67.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.79% in the past 14 days, which was lower than the 76.84% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.53, while its 200-day Moving Average is $10.01. However, in the short run, Wave Life Sciences Ltd’s stock first resistance to watch stands at $7.14. Second resistance stands at $7.34. The third major resistance level sits at $7.52. If the price goes on to break the first support level at $6.77, it is likely to go to the next support level at $6.58. The third support level lies at $6.39 if the price breaches the second support level.

Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats

The company with the Market Capitalisation of 1.07 billion has total of 154,134K Shares Outstanding. Its annual sales at the moment are 108,300 K in contrast with the sum of -97,010 K annual income. Company’s last quarter sales were recorded 9,180 K and last quarter income was -46,880 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.